NFA
AXDX

Nationwide Fund Advisors’s Accelerate Diagnostics AXDX Stock Holding History

Nationwide Fund Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,973
Closed -$892K – 201
2017
Q3 		$892K Buy
3,973
+312
+9% +$76.6K ﹤0.01% 1860
2017
Q2 		$1M Buy
3,661
+2,298
+169% +$623K ﹤0.01% 1776
2017
Q1 		$330K Sell
1,363
-88
-6% -$20.1K ﹤0.01% 2371
2016
Q4 		$301K Buy
1,451
+1
+0.1% +$237 ﹤0.01% 2428
2016
Q3 		$395K Sell
1,450
-142
-9% -$31.4K ﹤0.01% 2292
2016
Q2 		$229K Hold
1,592
– – ﹤0.01% 2542
2016
Q1 		$229K Buy
1,592
+151
+10% +$21.3K ﹤0.01% 2472
2015
Q4 		$310K Buy
1,441
+40
+3% +$7.3K ﹤0.01% 2336
2015
Q3 		$227K Hold
1,401
– – ﹤0.01% 2498
2015
Q2 		$362K Sell
1,401
-272
-16% -$65K ﹤0.01% 2426
2015
Q1 		$376K Sell
1,673
-51
-3% -$10.7K ﹤0.01% 2380
2014
Q4 		$331K Sell
1,724
-11
-0.6% -$2.35K ﹤0.01% 2406
2014
Q3 		$373K Sell
1,735
-6
-0.3% -$1.17K ﹤0.01% 2378
2014
Q2 		$453K Buy
1,741
+893
+105% +$195K ﹤0.01% 2313
2014
Q1 		$185K Hold
848
– – ﹤0.01% 2515
2013
Q4 		$104K Buy
848
+22
+3% +$2.94K ﹤0.01% 2941
2013
Q3 		$111K Buy
826
+496
+150% +$44.3K ﹤0.01% 2903
2013
Q2 		$27K Buy
+330
New +$24.5K ﹤0.01% 3052

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Nationwide Fund Advisors's AXDX Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Accelerate Diagnostics (AXDX) in Q4 2017, closing a stake of 3,973 shares — an estimated $892K sold.

Nationwide Fund Advisors first reported a position in AXDX in Q2 2013 and held it in 18 quarters. The position peaked at $1M in Q2 2017. 118 funds tracked by Wall St. Rank hold AXDX as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Accelerate Diagnostics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 3,973 Accelerate Diagnostics shares in Q4 2017, an estimated $892K.
  • Nationwide Fund Advisors first reported a position in Accelerate Diagnostics in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Accelerate Diagnostics position peaked at $1M in Q2 2017.
  • 118 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.